Evidence map›Paper›PMID 38002314›Full record

ArticleBiomolecules2023

Bioactive Compounds from an Endophytic

Özge Demir, Haoxuan Zeng, Barbara Schulz, Hedda Schrey, Michael Steinert, Marc Stadler, Frank Surup

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Strong antagonism of an endophyte ofApplied and environmental microbiology · 2024
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Özge DemirDepartment Microbial Drugs, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, 38124 Braunschweig, Germany.
Haoxuan ZengDepartment Microbial Drugs, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, 38124 Braunschweig, Germany.
Barbara SchulzInstitute of Microbiology, Technical University of Braunschweig, Spielmannstraße 7, 38106 Braunschweig, Germany.ORCID 0000-0002-9274-1134
Hedda SchreyDepartment Microbial Drugs, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, 38124 Braunschweig, Germany.
Michael SteinertInstitute of Microbiology, Technical University of Braunschweig, Spielmannstraße 7, 38106 Braunschweig, Germany.ORCID 0000-0001-9197-6305
Marc StadlerDepartment Microbial Drugs, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, 38124 Braunschweig, Germany.ORCID 0000-0002-7284-8671
Frank SurupDepartment Microbial Drugs, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, 38124 Braunschweig, Germany.ORCID 0000-0001-5234-8525
Helmholtz Centre for Infection Research · DETechnische Universität Braunschweig · DE

Funding

Fachagentur Nachwachsende Rohstoffe 2219WK22F4Republic of Türkiye Ministry of National Education Stipend to Ö.D.
6 · The paper itself

Abstract

A fungal endophyte originating from the Canary Islands was identified as a potent antagonist against the fungal phytopathogen

Indexed as

Antifungal AgentsStaphylococcus aureusAscomycotaPyrrolidinonesTetrahydronaphthalenesAntifungal AgentsCJ 17572PyrrolidinonesTetrahydronaphthalenesbiocontrolbiofilm inhibitionendophytic fungiHymenoscyphus fraxineusnatural productssecondary metabolitessemi-synthesisstructure elucidation

Identifiers

PMID38002314
PMCPMC10669340
OpenAlexW4388523372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.